Infectious Diseases 1010 - Infectious Disease Alert - Oct 01, 2006

Target Audience:

This activity is intended for the infectious disease specialist.


AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 3.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


Physician Editor
Stan Deresinski, MD, FACP
Clinical Professor of Medicine
Associate Chief of Infectious Diseases
Santa Clara Valley Medical Center

Board Member and Peer Reviewer
Connie Price, MD
Assistant Professor
University of Colorado School of Medicine

Board Member and Updates Author
Carol A. Kemper, MD, FACP
Clinical Associate Professor of Medicine
Stanford University
Division of Infectious Diseases
Santa Clara Valley Medical Center
Section Editor
Section Editor

Associate Editors
Dean L. Winslow, MD, FACP
Division of AIDS Medicine
Santa Clara Valley Medical Center
Clinical Professor
Stanford University School of Medicine Section Editor, HIV

J. Peter Donnelly, PHD
Clinical Microbiologist
University Hospital
Nijmegen, The Netherlands
Section Editor, Microbiology

Jessica Song, MA, PharmD
Assistant Professor
Pharmacy Practice
University of the Pacific
Stockton, CA
Pharmacy Clerkship and Coordinator
Santa Clara Valley Medical Center Section Editor
Managed Care

Kiron Punwani, PharmD Candidate
University of the Pacific School of Pharmacy

Shannon Suedkamp, PharmD Candidate
University of the Pacific School of Pharmacy

Diem Nguyen, PharmD Candidate
University of the Pacific School of Pharmacy


  • Darunavir (TMC114) Approved by the FDA
  • CDAD: Novel Therapeutics
  • Preventing Fungal Infection: Does Clean Air Matter?
  • Hepatocyte Apoptosis in Hepatitis C/HIV Co-Infection
  • Update on the CNS Adverse Effects of Sustiva® (Efavirenz)
  • Updates


  • To discuss diagnosis and treatment of infectious diseases
  • To present current data regarding use of new antibiotics for commonly diagnosed diseases and new uses for traditional drugs
  • To present the latest information regarding the pros, cons, and cost-effectiveness of new and traditional diagnostic tests
  • To discuss new information regarding how infectious diseases (eg, AIDS) are transmitted and how such information can lead to the development of new therapy

Financial Disclosure:

Infectious Disease Alert’s Physician Editor, Stan Deresinski, MD, FACP, serves on the speaker’s bureau of Merck, Pharmacia, GlaxoSmithKline, Pfizer, Bayer, and Wyeth, and does research for Merck.

Associate Editor, Dean L. Winslow, MD, FACP, is a consultant for Bayer Diagnostics, and is on the speaker’s bureau for GlaxoSmithKline and Pfizer.

Associate Editor, Peter Donnelly, PhD, is a consultant for Ortho Biotech, and does research for Janssen, Merck, Novartis, Numico, Pharmacia, and Pfizer.

Peer Reviewer, Connie Price, MD, Updates Author, Carol A. Kemper, MD, FACP, Associate Editor, Jessica C. Song, MA, PharmD, and PharmD Candidates Kiron Punwani, Shannon Suedkamp, and Diem Nguyen, report no consultant, stockholder, speaker’s bureau, research, or other financial relationship with any company related to this field of study.

Copyright 2006 AHC Media. All rights reserved.